Φορτώνει......
Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
Therapy for adult acute lymphoblastic leukemia (ALL) with multiagent cytotoxic chemotherapy has not been as successful as that for pediatric patients. The advent of targeted monoclonal antibodies against common cell surface antigens (i.e. CD19, CD20, and CD22) has resulted in improved outcomes witho...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Hematol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7992772/ https://ncbi.nlm.nih.gov/pubmed/33815734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718812013 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|